
CNS Therapy is dedicated to alleviating chronic pain and restoring the autonomic nervous system through innovative therapies. Their unique approach combines operant behavioral therapy with a patented device known as Systolic Extinction Training (SET), which enhances learning and resets the autonomic nervous system. This low-risk, non-invasive method has shown high success rates in helping chronic pain patients significantly reduce or eliminate their pain, allowing them to return to their daily lives. Utilizing AI to monitor physiological parameters, CNS Therapy stands out in the healthcare market by offering a comprehensive solution that integrates psychological training with neuromodulation.

CNS Therapy is dedicated to alleviating chronic pain and restoring the autonomic nervous system through innovative therapies. Their unique approach combines operant behavioral therapy with a patented device known as Systolic Extinction Training (SET), which enhances learning and resets the autonomic nervous system. This low-risk, non-invasive method has shown high success rates in helping chronic pain patients significantly reduce or eliminate their pain, allowing them to return to their daily lives. Utilizing AI to monitor physiological parameters, CNS Therapy stands out in the healthcare market by offering a comprehensive solution that integrates psychological training with neuromodulation.
Founded: 2014
Headquarters: Lindau, Bayern, Germany
Core offering: Systolic Extinction Training (SET) device + operant behavioral eLearning and biometric monitoring
Therapeutic focus: Non-invasive treatment for chronic pain by restoring autonomic function
Recent funding activity: Non-equity assistance round reported May 24, 2024
Chronic pain and dysregulated autonomic nervous system / baroreflex dysfunction
2014
Biotechnology
Reported non-equity assistance round with MassChallenge Switzerland noted as lead investor
“DayOne accelerator, MassChallenge Switzerland, StartUp Health”